title: Oral vitamin E prophylaxis in the protection of newborn myocardium from global ischemia.
abstract: BACKGROUND
  Oxygen-derived free radicals have been implicated in the pathophysiology of myocardial reperfusion injury after ischemic insult. Recent studies have demonstrated that free radical scavengers could afford protection to the mature myocardium from these injuries. The purpose of this study was to investigate whether oral vitamin E pretreatment could improve the tolerance of newborn hearts to ischemia.
  
  
  METHODS
  Two groups of six newborn piglet hearts were randomly studied in an isolated, perfused Langendorff heart model. Group I control hearts were subjected to 30 minutes of cold perfusion at 15 degrees C, in which profound hypothermia was achieved over a period of 10 minutes. This was followed by 90 minutes of global ischemia arrest and 30 minutes of normothermic reperfusion. Group II piglets were pretreated with d-alpha-tocopherol (vitamin E) given by oral gavage for 4 days before similar experimentation. Baseline functional parameters were recorded before cold perfusion by a left intraventricular balloon inflated to a diastolic pressure of 11 to 14 mm Hg and repeated at the end of 30 minutes of normothermic reperfusion. Creatine phosphokinase leakage in the perfusate was analyzed immediately after reperfusion and the pressure/volume ratio was obtained at the conclusion of each experiment.
  
  
  RESULTS
  Postischemic functional recovery of vitamin E-pretreated group II hearts was improved significantly compared with the control hearts (group I). Left ventricular diastolic pressure was 87.5% +/- 2.3% versus 66.1% +/- 2.3%, +dp/dt was 94.5% +/- 2.2% versus 68.0% +/- 5.6%, -dp/dt was 93.0% +/- 2.4% versus 69.6% +/- 6.0%, mean left ventricular end-diastolic pressure was 13.0 +/- 0.8 versus 22.0 +/- 3.5 mm Hg, and pressure/volume ratio was 29.2 +/- 2.3 versus 41.8 +/- 4.3 mm Hg/ml, respectively (p less than 0.05). Perfusate creatine phosphokinase leakage was also reduced significantly from 112.5 +/- 17.9 to 56.2 +/- 4.0 IU/L (p less than 0.05) in group II.
  
  
  CONCLUSIONS
  Oral vitamin E pretreatment improved the ischemic tolerance of newborn myocardium and therefore might be considered a valuable, effective, and inexpensive method of myocardial protection.
authors.affiliation: Division of Cardiovascular and Thoracic Surgery, McGill University, Montreal, Quebec, Canada.
authors.forename: D
authors.initials: D
authors.lastname: Shum-Tim
authors.forename: C I
authors.initials: CI
authors.lastname: Tchervenkov
authors.forename: R C
authors.initials: RC
authors.lastname: Chiu
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001834:Body Water / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control*; D003402:Creatine Kinase / Q000378:metabolism; D006321:Heart / Q000502:physiology; D006352:Heart Ventricles; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism; D010539:Permeability; D012016:Reference Values; D014810:Vitamin E / Q000627:therapeutic use*
chemical_list: D014810:Vitamin E; D003402:Creatine Kinase